首页 > 最新文献

Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych最新文献

英文 中文
[Changes in blood pressure and methods of blood pressure monitoring in patients with type-1 diabetes]. [1型糖尿病患者血压变化及血压监测方法]。
Ewa Pańkowska, Dorota Golicka

Both diabetes mellitus and hypertension are major risk factors for cardiovascular, renal and atherosclerotic vascular disease. Hypertension is known to be more common in patients with diabetes than in the general population. Patients with diabetes mellitus are at high risk for renal injury, which may be exacerbated by abnormalities in circadian blood pressure pattern. Ambulatory blood pressure monitoring (ABPM) permits the observation of blood pressure throughout day and night in a non-medical environment, and to quantify the circadian blood pressure variability. Recent studies with the use of ambulatory blood pressure monitoring have shown that the physiological nocturnal fall in blood pressure is blunted or absent in some individuals with type 1 diabetes who are completely normotensive by conventional criteria. Patients with type 1 diabetes and microalbuminuria have higher nocturnal blood pressure than either patients with type 1 diabetes and normal albumin excretion or age-matched controls. Moreover, changes in the circadian pattern of blood pressure in patients with type 1 diabetes may predict the development of albuminuria.

糖尿病和高血压都是心血管、肾脏和动脉粥样硬化性血管疾病的主要危险因素。众所周知,高血压在糖尿病患者中比在一般人群中更常见。糖尿病患者是肾损伤的高危人群,昼夜血压模式异常可能加重肾损伤。动态血压监测(ABPM)允许在非医疗环境下全天和夜间观察血压,并量化昼夜血压变化。最近使用动态血压监测的研究表明,在一些按常规标准完全正常的1型糖尿病患者中,血压的夜间生理性下降是迟钝的或没有的。1型糖尿病和微量白蛋白尿患者的夜间血压高于1型糖尿病和白蛋白排泄正常的患者或年龄匹配的对照组。此外,1型糖尿病患者血压昼夜节律模式的变化可能预测蛋白尿的发生。
{"title":"[Changes in blood pressure and methods of blood pressure monitoring in patients with type-1 diabetes].","authors":"Ewa Pańkowska,&nbsp;Dorota Golicka","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Both diabetes mellitus and hypertension are major risk factors for cardiovascular, renal and atherosclerotic vascular disease. Hypertension is known to be more common in patients with diabetes than in the general population. Patients with diabetes mellitus are at high risk for renal injury, which may be exacerbated by abnormalities in circadian blood pressure pattern. Ambulatory blood pressure monitoring (ABPM) permits the observation of blood pressure throughout day and night in a non-medical environment, and to quantify the circadian blood pressure variability. Recent studies with the use of ambulatory blood pressure monitoring have shown that the physiological nocturnal fall in blood pressure is blunted or absent in some individuals with type 1 diabetes who are completely normotensive by conventional criteria. Patients with type 1 diabetes and microalbuminuria have higher nocturnal blood pressure than either patients with type 1 diabetes and normal albumin excretion or age-matched controls. Moreover, changes in the circadian pattern of blood pressure in patients with type 1 diabetes may predict the development of albuminuria.</p>","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"11 1","pages":"33-7"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25074189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Adrenal function in girls with hirsutism]. [多毛症女孩的肾上腺功能]。
Beata Wikiera, Renata B Wasikowa

Unlabelled: The aim of our study was to estimate the adrenal function in hirsute girls.

Material and methods: 57 girls with hirsutism aged from 12 to 19 years, mean age 15.95 years, were involved into the study. The research was performed in early and middle follicular stage. Menstrual disorders were observed in 78% of them. Hirsutism was estimated with Ferriman-Gallwey scale (mean value 13+/-1.58), mean BMI was 22.7. The patients were divided into 3 groups: group 1 with clinical and laboratory symptoms of PCOS, n=29; group 2 with menstrual disorders and without elevated androgen level, n=15; group 3 without menstrual disorders and without elevated androgen level, n=13.

Results: 17OHP level was the highest in group I (1.17+/-0.58 ng/ml). Diurnal cortisol profile was regular in all patients. After Synacthen injection cortisol level rose in all groups to the similar values at 60 min. The same stimuli induced intensive 17OHP secretion in group 1 (2.42+/-2.02 ng/ml) at 30 min statistically higher than in group 2 (1.46+/-0.95 ng/ml), (p=0.045). None had 21-hydroxysase defect. There were positive correlation between levels of 17OHP and LH (r=0.38), 17OHP and T (r=0.39), 17OHP and LH/FSH (r=0.40) CONCLUSIONS: 17OHP level in patients with PCOS is significantly higher then in other hirsute girls. High 17OHP and normal cortisol level after Synacthen administration in PCOS girls point that activity of enzymes involved in 17OHP production is augmented.

未标记:我们研究的目的是估计多毛女孩的肾上腺功能。材料与方法:选取年龄12 ~ 19岁的多毛症女生57例,平均年龄15.95岁。研究在卵泡早期和中期进行。其中78%的患者出现月经紊乱。用Ferriman-Gallwey量表评估多毛症(平均值13±1.58),平均BMI为22.7。将患者分为3组:1组有PCOS临床及实验室症状,n=29;2组有月经紊乱且雄激素水平未升高,n=15;3组无月经紊乱,无雄激素水平升高,n=13。结果:17OHP以ⅰ组最高(1.17+/-0.58 ng/ml)。所有患者的皮质醇日变化均有规律。注射Synacthen后,各组皮质醇水平在60 min时均升高至相近水平。相同刺激下,组1在30 min时强烈分泌17OHP (2.42+/-2.02 ng/ml)高于组2 (1.46+/-0.95 ng/ml),差异有统计学意义(p=0.045)。21-羟基酶均无缺陷。17OHP与LH (r=0.38)、17OHP与T (r=0.39)、17OHP与LH/FSH (r=0.40)呈正相关。结论:PCOS患者17OHP水平显著高于其他多毛女孩。PCOS女孩服用Synacthen后17OHP升高,皮质醇水平正常,表明参与17OHP产生的酶活性增强。
{"title":"[Adrenal function in girls with hirsutism].","authors":"Beata Wikiera,&nbsp;Renata B Wasikowa","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Unlabelled: </strong>The aim of our study was to estimate the adrenal function in hirsute girls.</p><p><strong>Material and methods: </strong>57 girls with hirsutism aged from 12 to 19 years, mean age 15.95 years, were involved into the study. The research was performed in early and middle follicular stage. Menstrual disorders were observed in 78% of them. Hirsutism was estimated with Ferriman-Gallwey scale (mean value 13+/-1.58), mean BMI was 22.7. The patients were divided into 3 groups: group 1 with clinical and laboratory symptoms of PCOS, n=29; group 2 with menstrual disorders and without elevated androgen level, n=15; group 3 without menstrual disorders and without elevated androgen level, n=13.</p><p><strong>Results: </strong>17OHP level was the highest in group I (1.17+/-0.58 ng/ml). Diurnal cortisol profile was regular in all patients. After Synacthen injection cortisol level rose in all groups to the similar values at 60 min. The same stimuli induced intensive 17OHP secretion in group 1 (2.42+/-2.02 ng/ml) at 30 min statistically higher than in group 2 (1.46+/-0.95 ng/ml), (p=0.045). None had 21-hydroxysase defect. There were positive correlation between levels of 17OHP and LH (r=0.38), 17OHP and T (r=0.39), 17OHP and LH/FSH (r=0.40) CONCLUSIONS: 17OHP level in patients with PCOS is significantly higher then in other hirsute girls. High 17OHP and normal cortisol level after Synacthen administration in PCOS girls point that activity of enzymes involved in 17OHP production is augmented.</p>","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"11 1","pages":"27-31"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25074188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The role of ghrelin in the regulation of energy homeostasis]. [胃饥饿素在调节能量稳态中的作用]。
Ewa Otto Buczkowska

Ghrelin, a novel 28 amino acid peptide, is the endogenous ligand for the growth hormone secretagogue receptor. The stomach is the primary source of circulating ghrelin, but it is also produced by the intestines, kidneys, hypothalamus, pituitary, placenta and pancreas. Ghrelin has been recognized as an important regulator of GH secretion and have important roles in energy homeostasis, glucose and lipid metabolism, reproduction, cardiovascular function, and immunity. Ghrelin has been shown to have a physiological role in the control of food intake, acting as an orexigenic hormone, probably by stimulating NPY production in contrast to the actions of leptin.

生长素(Ghrelin)是一种由28个氨基酸组成的新型肽,是生长激素促分泌素受体的内源性配体。胃是胃饥饿素循环的主要来源,但它也由肠、肾、下丘脑、垂体、胎盘和胰腺产生。Ghrelin被认为是生长激素分泌的重要调节因子,在能量稳态、糖脂代谢、生殖、心血管功能和免疫等方面具有重要作用。Ghrelin已被证明在控制食物摄入方面具有生理作用,作为一种促氧激素,可能是通过刺激NPY的产生而与瘦素的作用相反。
{"title":"[The role of ghrelin in the regulation of energy homeostasis].","authors":"Ewa Otto Buczkowska","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Ghrelin, a novel 28 amino acid peptide, is the endogenous ligand for the growth hormone secretagogue receptor. The stomach is the primary source of circulating ghrelin, but it is also produced by the intestines, kidneys, hypothalamus, pituitary, placenta and pancreas. Ghrelin has been recognized as an important regulator of GH secretion and have important roles in energy homeostasis, glucose and lipid metabolism, reproduction, cardiovascular function, and immunity. Ghrelin has been shown to have a physiological role in the control of food intake, acting as an orexigenic hormone, probably by stimulating NPY production in contrast to the actions of leptin.</p>","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"11 1","pages":"39-42"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25074190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Inappropriate sexual differentiation of sex reversal type in 16-year-old boy with male phenotype]. [16岁男性表现型男孩性反转型的不适当性分化]。
Jerzy Starzyk, Aleksandra Górska, Dominika Januś

We present a case of a 16-year-old boy with gynecomastia and symptoms of delayed puberty (relatively small testes and penis), who attended the Endocrinology Clinic. Pubic hair development was normal. Basic hormonal blood tests showed a primary testicular lesion (hypergonadotropic hypogonadism). The result of karyotype examination showed female karyotype 46, XX. Based on those results the boy was diagnosed to be 46, XX male. A replacement testosterone therapy was administered. He stays in follow-up for gonad observation. The authors emphasize the possibility of establishing the diagnosis of a severe disorder belonging to the group of inappropriate sex differentiation of sex reversal type not earlier than in teenage adolescents, who present symptoms of delayed puberty. In such cases the main rule in establishing a final diagnosis is played by a physical examination with evaluation of sex development, as well as basic hormonal blood tests and karyotype result. Their correct interpretation is possible only by a physician who has reliable knowledge of the physiology of male sex determination.

我们报告一个16岁的男性男性乳房发育症和青春期延迟的症状(相对较小的睾丸和阴茎),谁参加了内分泌诊所。阴毛发育正常。基本的激素血液检查显示原发性睾丸病变(促性腺激素亢进性性腺功能减退)。核型检查结果为女性核型46,XX。根据这些结果,该男孩被诊断为46岁,XX岁男性。给予替代睾酮治疗。他继续进行性腺观察。作者强调,不早于出现青春期延迟症状的青少年,建立属于性逆转型不适当性别分化组的严重障碍的诊断的可能性。在这种情况下,确定最终诊断的主要规则是通过评估性发育的身体检查,以及基本的激素血液检查和核型结果。只有具备男性性别决定生理方面可靠知识的医生才有可能对其作出正确的解释。
{"title":"[Inappropriate sexual differentiation of sex reversal type in 16-year-old boy with male phenotype].","authors":"Jerzy Starzyk,&nbsp;Aleksandra Górska,&nbsp;Dominika Januś","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We present a case of a 16-year-old boy with gynecomastia and symptoms of delayed puberty (relatively small testes and penis), who attended the Endocrinology Clinic. Pubic hair development was normal. Basic hormonal blood tests showed a primary testicular lesion (hypergonadotropic hypogonadism). The result of karyotype examination showed female karyotype 46, XX. Based on those results the boy was diagnosed to be 46, XX male. A replacement testosterone therapy was administered. He stays in follow-up for gonad observation. The authors emphasize the possibility of establishing the diagnosis of a severe disorder belonging to the group of inappropriate sex differentiation of sex reversal type not earlier than in teenage adolescents, who present symptoms of delayed puberty. In such cases the main rule in establishing a final diagnosis is played by a physical examination with evaluation of sex development, as well as basic hormonal blood tests and karyotype result. Their correct interpretation is possible only by a physician who has reliable knowledge of the physiology of male sex determination.</p>","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"11 1","pages":"55-7"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25074711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Could the expression of L-selectin be an early marker of arterial hypertension and microangiopathy in the course of type 1 diabetes mellitus in juvenile patients?]. [l -选择素的表达能否作为1型糖尿病青少年患者病程中动脉高血压和微血管病变的早期标志?]
Przemysław Pawłowski, Mirosława Urban, Jadwiga Peczyńska

Background: Autoreactive T lymphocytes participate in the development of type 1 diabetes mellitus. The migration of T cells is initiated by increased expression of L-selectin on the cellular membrane of lymphocyte. Recently, a correlation between the concentration of sL-selectin and the develop-ment of diabetic retinopathy, atherosclerosis and arterial hypertension was stated.

Objectives: The purpose of this study was to evaluate whether the expression of L-selectin on lymphocytes T alters in the course of the disease -- diabetes lasting less than 5 years and over 5 years; to assess a relationship between the percentage of L-selectin on T cells and the evolution of vascular complications; to elucidate whether the percentage of peripheral blood T lymphocytes expressing L-selectin could be an early marker of angiopathy in juvenile patients.

Material and methods: The study was carried out on 60 children and adolescents (aged 9-20) with diagnosed type 1 diabetes: a) (20 n) with the disease lasting <5 years, b) (20 n) with type 1 diabetes lasting >5 years without vascular complications, c) (20 n) with type 1 diabetes and vascular complications (microalbuminuria, arterial hypertension, diabetic retinopathy). The control group consisted of 20 healthy volunteers (aged 6-17). The expression of adhesion molecules has been evaluated by using three-color flow cytometry (Coulter EPICS XL). HbA1c concentration has been analysed by a liquid chromatography technique HPLC-Variant (Bio-Rad).

Results: The percentage of T lymphocytes expressing L-selectin was significantly increased in all groups of patients with type 1 diabetes versus healthy controls (p<0.005 and p<0.001, in groups without complications and with angiopathy, respectively). Moreover in patients with diagnosed arterial hypertension the percentage of T lymphocytes expressing L-selectin was higher than in patients in whom arterial hypertension was not developed (p<0.05).

Conclusions: In juvenile patients with type 1 diabetes the percentage of T lymphocytes expressing L-selectin was increased independently on the du-ration of the disease. In children with type 1 diabetes and diagnosed vascular complications the highest percentage of T lymphocytes expressing L-selectin was found.

背景:自身反应性T淋巴细胞参与1型糖尿病的发生发展。T细胞的迁移是由淋巴细胞细胞膜上l -选择素的表达增加引起的。最近,sl -选择素的浓度与糖尿病视网膜病变、动脉粥样硬化和动脉高血压的发展之间存在相关性。目的:本研究的目的是评估l -选择素在T淋巴细胞上的表达是否在疾病过程中发生改变-持续时间小于5年和大于5年的糖尿病;评估T细胞上l -选择素的百分比与血管并发症的演变之间的关系;阐明外周血T淋巴细胞表达l -选择素的百分比是否可以作为青少年患者血管病变的早期标志。材料和方法:研究对象为60例诊断为1型糖尿病的儿童和青少年(9-20岁):a)(20例)病程持续5年无血管并发症,c)(20例)有1型糖尿病及血管并发症(微量白蛋白尿、动脉高血压、糖尿病视网膜病变)。对照组由20名6-17岁的健康志愿者组成。采用三色流式细胞术(Coulter EPICS XL)检测粘附分子的表达。采用HPLC-Variant (Bio-Rad)液相色谱技术分析HbA1c浓度。结果:各组1型糖尿病患者中表达l -选择素的T淋巴细胞百分比均较健康对照组显著升高(结论:在青少年1型糖尿病患者中,表达l -选择素的T淋巴细胞百分比随病程的延长而独立升高。在诊断为血管并发症的1型糖尿病患儿中,T淋巴细胞表达l -选择素的比例最高。
{"title":"[Could the expression of L-selectin be an early marker of arterial hypertension and microangiopathy in the course of type 1 diabetes mellitus in juvenile patients?].","authors":"Przemysław Pawłowski,&nbsp;Mirosława Urban,&nbsp;Jadwiga Peczyńska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Autoreactive T lymphocytes participate in the development of type 1 diabetes mellitus. The migration of T cells is initiated by increased expression of L-selectin on the cellular membrane of lymphocyte. Recently, a correlation between the concentration of sL-selectin and the develop-ment of diabetic retinopathy, atherosclerosis and arterial hypertension was stated.</p><p><strong>Objectives: </strong>The purpose of this study was to evaluate whether the expression of L-selectin on lymphocytes T alters in the course of the disease -- diabetes lasting less than 5 years and over 5 years; to assess a relationship between the percentage of L-selectin on T cells and the evolution of vascular complications; to elucidate whether the percentage of peripheral blood T lymphocytes expressing L-selectin could be an early marker of angiopathy in juvenile patients.</p><p><strong>Material and methods: </strong>The study was carried out on 60 children and adolescents (aged 9-20) with diagnosed type 1 diabetes: a) (20 n) with the disease lasting <5 years, b) (20 n) with type 1 diabetes lasting >5 years without vascular complications, c) (20 n) with type 1 diabetes and vascular complications (microalbuminuria, arterial hypertension, diabetic retinopathy). The control group consisted of 20 healthy volunteers (aged 6-17). The expression of adhesion molecules has been evaluated by using three-color flow cytometry (Coulter EPICS XL). HbA1c concentration has been analysed by a liquid chromatography technique HPLC-Variant (Bio-Rad).</p><p><strong>Results: </strong>The percentage of T lymphocytes expressing L-selectin was significantly increased in all groups of patients with type 1 diabetes versus healthy controls (p<0.005 and p<0.001, in groups without complications and with angiopathy, respectively). Moreover in patients with diagnosed arterial hypertension the percentage of T lymphocytes expressing L-selectin was higher than in patients in whom arterial hypertension was not developed (p<0.05).</p><p><strong>Conclusions: </strong>In juvenile patients with type 1 diabetes the percentage of T lymphocytes expressing L-selectin was increased independently on the du-ration of the disease. In children with type 1 diabetes and diagnosed vascular complications the highest percentage of T lymphocytes expressing L-selectin was found.</p>","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"11 3","pages":"147-52"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25642248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cardiovascular malformations in Turner syndrome]. [特纳综合征的心血管畸形]。
Maria Korpal-Szczyrska, Janina Aleszewicz-Baranowska, Bohdana Dorant, Piotr Potaz, Dorota Birkholz, Halina Kamińska

Background: A literature review indicates that the prevalence of cardiovascular malformations in patients with Turner syndrome ranges from 17 to 47 percent.

Objectives: The aim of the study was to evaluate the cardiovascular system in patients with Turner syndrome, controlled by the Pediatric Endocrinology Clinic of the Medical University of Gdansk.

Material and methods: The study included 55 females with Turner syndrome aged 3-20 years (mean age 9.6 years). The procedure included an interview, subject examination, chest X-rays and echocardiography. The echocardiography included M-mode measurements, two-dimensional evaluations from all standard planes, pulsed and continuous wave Doppler as well as color flow mapping. In selected cases, cardiologic examination embraced also cardiac catheterization, cineangiography and continuous 24-hour blood pressure measurement.

Results: Cardiovascular malformations were found in 18 out of 55 females (32.7%). Aortic coarctation was detected in 9 out of 18 patients (50%), bicuspid aortic valve in 33%, and aortic insufficiency in 22% of them. 78% of Turner subjects with cardiovascular malformations had monosomy (45,X). All females, except one, with aortic coarctation, had a 45,X karyotype. One aortic coarctation was diagnosed during prenatal examination. Before the last medical examination, 9 females had undergone a surgical treatment. In one case, the surgical treatment was preceded by a balloon angioplasty. Due to a recoarctation, one female was submitted to an additional balloon angioplasty. One female died during the post surgical period suffering from aortic wall injury. In four cases, despite successful surgeries, there still remains an arterial hypertension requiring pharmacological treatment. In 4 out of 18 cases (22%) isolated aortic valves defects were diagnosed, however, at present time they do not require any surgical treatment. In three cases, echocardiographic examination indicated a persistent left superior vena cava and aneurysm atrial septal defect with an intact septum.

Conclusions: Due to a high prevalence of cardiovascular malformations, girls with Turner syndrome should be monitored by a pediatric cardiologist. In each case, female with Turner syndrome should be submitted to echocardiography. Also a careful control of the blood pressure is indicated.

背景:一项文献综述表明,特纳综合征患者心血管畸形的患病率为17%至47%。目的:该研究的目的是评估特纳综合征患者的心血管系统,由格但斯克医科大学儿科内分泌学诊所控制。材料与方法:研究对象为年龄3 ~ 20岁的特纳综合征女性55例,平均年龄9.6岁。检查过程包括面谈、受试者检查、胸部x光检查和超声心动图检查。超声心动图包括m模式测量,所有标准平面的二维评估,脉冲和连续波多普勒以及彩色血流图。在选定的病例中,心脏检查还包括心导管检查、血管造影和连续24小时血压测量。结果:55例女性患者中有18例出现心血管畸形,占32.7%。18例患者中有9例(50%)出现主动脉缩窄,33%出现双尖瓣主动脉瓣,22%出现主动脉不全。有心血管畸形的Turner受试者中有78%为单体(45,X)。除一例主动脉缩窄外,所有女性的核型均为45x。产前检查诊断主动脉缩窄1例。在上次体检之前,有9名女性接受了手术治疗。在一个病例中,手术治疗之前进行了球囊血管成形术。由于再狭窄,一名女性被提交了额外的球囊血管成形术。一例女性患者术后因主动脉壁损伤死亡。在四个病例中,尽管手术成功,仍然有动脉高血压需要药物治疗。18例中有4例(22%)被诊断为孤立性主动脉瓣缺损,然而,目前他们不需要任何手术治疗。在三个病例中,超声心动图检查显示持续性左上腔静脉和动脉瘤房间隔缺损,室间隔完整。结论:由于心血管畸形的高患病率,特纳综合征的女孩应该由儿科心脏病专家进行监测。在每种情况下,女性特纳综合征应提交超声心动图。此外,还需要仔细控制血压。
{"title":"[Cardiovascular malformations in Turner syndrome].","authors":"Maria Korpal-Szczyrska,&nbsp;Janina Aleszewicz-Baranowska,&nbsp;Bohdana Dorant,&nbsp;Piotr Potaz,&nbsp;Dorota Birkholz,&nbsp;Halina Kamińska","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>A literature review indicates that the prevalence of cardiovascular malformations in patients with Turner syndrome ranges from 17 to 47 percent.</p><p><strong>Objectives: </strong>The aim of the study was to evaluate the cardiovascular system in patients with Turner syndrome, controlled by the Pediatric Endocrinology Clinic of the Medical University of Gdansk.</p><p><strong>Material and methods: </strong>The study included 55 females with Turner syndrome aged 3-20 years (mean age 9.6 years). The procedure included an interview, subject examination, chest X-rays and echocardiography. The echocardiography included M-mode measurements, two-dimensional evaluations from all standard planes, pulsed and continuous wave Doppler as well as color flow mapping. In selected cases, cardiologic examination embraced also cardiac catheterization, cineangiography and continuous 24-hour blood pressure measurement.</p><p><strong>Results: </strong>Cardiovascular malformations were found in 18 out of 55 females (32.7%). Aortic coarctation was detected in 9 out of 18 patients (50%), bicuspid aortic valve in 33%, and aortic insufficiency in 22% of them. 78% of Turner subjects with cardiovascular malformations had monosomy (45,X). All females, except one, with aortic coarctation, had a 45,X karyotype. One aortic coarctation was diagnosed during prenatal examination. Before the last medical examination, 9 females had undergone a surgical treatment. In one case, the surgical treatment was preceded by a balloon angioplasty. Due to a recoarctation, one female was submitted to an additional balloon angioplasty. One female died during the post surgical period suffering from aortic wall injury. In four cases, despite successful surgeries, there still remains an arterial hypertension requiring pharmacological treatment. In 4 out of 18 cases (22%) isolated aortic valves defects were diagnosed, however, at present time they do not require any surgical treatment. In three cases, echocardiographic examination indicated a persistent left superior vena cava and aneurysm atrial septal defect with an intact septum.</p><p><strong>Conclusions: </strong>Due to a high prevalence of cardiovascular malformations, girls with Turner syndrome should be monitored by a pediatric cardiologist. In each case, female with Turner syndrome should be submitted to echocardiography. Also a careful control of the blood pressure is indicated.</p>","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"11 4","pages":"211-4"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25641768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?]. [儿童和青少年1型糖尿病患者体内胱抑素C水平是否为糖尿病肾病的早期标志?]
Jadwiga Peczyńska, Mirosława Urban, Barbara Głowińska, Bozena Florys

Background: The most important complication in the course of diabetes mellitus type I is diabetic nephropathy. Nowadays, apart from assessing the increased amount of albumins in urine, we are not able to identify early enough these patients whose health might be endangered by nephropathy. Looking for other biochemical indicators which could mark the early symptoms of kidney damage/renal malfunction seems to be justified.

Objectives: 1. What is the concentration of cystatin C among children and teenagers suffering from diabetes mellitus type 1 and whether its level depends on the age of patient, the age in which the patient was affected with the disease, the length of the disease, metabolic compensation, diabetes control and the presence of microangiopathy? 2. Is there any interdependence between cystatin C and microalbuminuria and the renal efficiency rates?

Material: Study group. A group of 130 patients (60 girls and 70 boys aged from 7 and 20,8) who have been suffering from juvenile diabetes from 1 to 17 years was examined. The control group were healthy youngsters, matched for age and sex, without any /burdening/ medical history.

Methods: All the patients were examined in the following way: anthropometric measurements were taken, BMI in kg/m2 was defined, metabolic compensation based on HbA1c (%) was estimated. Ophthalmological examination and a circadian monitoring of arterial blood pressure were carried out. Microalbuminuria in a 24-hour urine collection was determined. In both groups glomerular filtration rate with the help of endogenous creatinine clearance and the concentration of cystatin C were evaluated. The results were subject to statistical analysis.

Results: The average age of the whole examined group was 15+/-3,0 the average disease length 6,85+/-3,36 years. The concentration of cystatin C among diabetic patients was higher in comparison with the control group (0.75+/-0.13 vs. 0.68+/-0.12 mg/l). It was also discovered that the concentration of cystatin C was increasing along with the length of the disease reaching the highest level in the group of patients suffering from this disease longer than 10 years (0.52+/-0.11 vs. 0.67+/-0.13 vs. 0.93+/-0.13 mg/l), which is again statistically significant. Moreover the concentration of cystatin C is higher among patients with insufficient diabetes control (0.765+/-0.12 mg/l vs. 0.71+/-0.12 pg/ml, p<0.05). These patients who additionally developed vascular complications (retinopathy, nephropathy, arterial hypertension) had significantly higher condensation of cystatin C (0.75+/-0.13 vs. 0.69+/-0.11 mg/l, p<0.05).

Discussion: Having considered the initial results, the following conclusion can be reached: only further, long-term research can supply us with the reliable data whether assessing the level of cystatin C concentration in children's and teenagers' ser

背景:1型糖尿病病程中最重要的并发症是糖尿病肾病。目前,除了评估尿液中白蛋白的增加量外,我们无法足够早地识别这些可能因肾病而危及健康的患者。寻找其他可以标记肾脏损害/肾功能障碍早期症状的生化指标似乎是合理的。目的:1。儿童和青少年1型糖尿病患者体内胱抑素C的浓度是多少?其水平是否与患者年龄、患者发病年龄、病程长短、代谢代偿、糖尿病控制和是否存在微血管病变有关?2. 胱氨酸抑素C、微量白蛋白尿和肾效率之间是否存在相互依赖关系?材料:学习小组。研究对象为1 ~ 17岁的青少年糖尿病患者130例(女孩60例,男孩70例,年龄从7岁到20岁不等)。对照组为健康青少年,年龄和性别匹配,无任何/负担/病史。方法:对所有患者进行以下检查:测量人体测量,定义BMI (kg/m2),估计基于HbA1c(%)的代谢代偿。进行眼科检查和动脉血压昼夜监测。在24小时尿液收集中测定微量白蛋白尿。在内源性肌酐清除率和胱抑素C浓度的帮助下,评估两组肾小球滤过率。结果要进行统计分析。结果:全组患者平均年龄15+/-3岁,平均病程6、85+/-3岁,36岁。糖尿病患者胱抑素C浓度高于对照组(0.75+/-0.13 vs. 0.68+/-0.12 mg/l)。我们还发现,胱氨酸抑制素C的浓度随着病程的延长而增加,在患病时间超过10年的患者组中达到最高水平(0.52+/-0.11 vs. 0.67+/-0.13 vs. 0.93+/-0.13 mg/l),同样具有统计学意义。糖尿病控制不充分的患者胱抑素C浓度较高(0.765+/-0.12 mg/l vs. 0.71+/-0.12 pg/ml)。讨论:结合初步结果,可以得出以下结论:只有进一步的长期研究才能为我们提供可靠的数据,评估儿童和青少年糖尿病患者血清胱抑素C浓度水平是否可以成为比微量白蛋白尿更早的肾功能障碍标志。
{"title":"[If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].","authors":"Jadwiga Peczyńska,&nbsp;Mirosława Urban,&nbsp;Barbara Głowińska,&nbsp;Bozena Florys","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The most important complication in the course of diabetes mellitus type I is diabetic nephropathy. Nowadays, apart from assessing the increased amount of albumins in urine, we are not able to identify early enough these patients whose health might be endangered by nephropathy. Looking for other biochemical indicators which could mark the early symptoms of kidney damage/renal malfunction seems to be justified.</p><p><strong>Objectives: </strong>1. What is the concentration of cystatin C among children and teenagers suffering from diabetes mellitus type 1 and whether its level depends on the age of patient, the age in which the patient was affected with the disease, the length of the disease, metabolic compensation, diabetes control and the presence of microangiopathy? 2. Is there any interdependence between cystatin C and microalbuminuria and the renal efficiency rates?</p><p><strong>Material: </strong>Study group. A group of 130 patients (60 girls and 70 boys aged from 7 and 20,8) who have been suffering from juvenile diabetes from 1 to 17 years was examined. The control group were healthy youngsters, matched for age and sex, without any /burdening/ medical history.</p><p><strong>Methods: </strong>All the patients were examined in the following way: anthropometric measurements were taken, BMI in kg/m2 was defined, metabolic compensation based on HbA1c (%) was estimated. Ophthalmological examination and a circadian monitoring of arterial blood pressure were carried out. Microalbuminuria in a 24-hour urine collection was determined. In both groups glomerular filtration rate with the help of endogenous creatinine clearance and the concentration of cystatin C were evaluated. The results were subject to statistical analysis.</p><p><strong>Results: </strong>The average age of the whole examined group was 15+/-3,0 the average disease length 6,85+/-3,36 years. The concentration of cystatin C among diabetic patients was higher in comparison with the control group (0.75+/-0.13 vs. 0.68+/-0.12 mg/l). It was also discovered that the concentration of cystatin C was increasing along with the length of the disease reaching the highest level in the group of patients suffering from this disease longer than 10 years (0.52+/-0.11 vs. 0.67+/-0.13 vs. 0.93+/-0.13 mg/l), which is again statistically significant. Moreover the concentration of cystatin C is higher among patients with insufficient diabetes control (0.765+/-0.12 mg/l vs. 0.71+/-0.12 pg/ml, p<0.05). These patients who additionally developed vascular complications (retinopathy, nephropathy, arterial hypertension) had significantly higher condensation of cystatin C (0.75+/-0.13 vs. 0.69+/-0.11 mg/l, p<0.05).</p><p><strong>Discussion: </strong>Having considered the initial results, the following conclusion can be reached: only further, long-term research can supply us with the reliable data whether assessing the level of cystatin C concentration in children's and teenagers' ser","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"11 3","pages":"141-6"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25642247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus]. [青春期前1型糖尿病儿童持续皮下注射胰岛素代谢控制及安全性评价]。
Mariola Minkina-Pedras, Przemysława Jarosz-Chobot, Ewa Małecka-Tendera, Grazyna Deja

Background: Currently continuous subcutaneous insulin infusion (CSII) as a method of functional intensive insulin therapy is the most physiological way to administer insulin. In recent years treatment with insulin pumps has been used more frequently in the paediatric diabetes whereas application of this kind of therapy is relatively new in the youngest group of children below the age of 10 years. THE AIM of the study was to assess the efficiency of CSII by means of insulin pumps in prepubertal children with type 1 diabetes mellitus (T1DM).

Materials and methods: Three groups of T1DM children on intensive insulin therapy were compared. Group 1 comprised 30 children with CSII in the mean age 6.7+/-2.2 SD years (CSII-1). In group 2 were 25 children treated with multiple injections (MI-1) in the mean age 7.0+/-1.5 SD years and in group 3-35 children in the mean age 13.9+/-2.1 SD years treated with CSII (group CSII-2). The age of children was comparable in group CSII-1 and MI-1. T1DM duration was the same for all groups. After 6, 12, 18 months the following parameters were analyzed: HbA1c, daily insulin requirement (DIR) U/kg, number of severe hypoglycemic episodes and diabetic ketoacidosis (DKA).

Results: After 18 months in CSII-1 HbA1c decreased insignificantly from 7.1% to 6.9% and DIR was significantly reduced from 0.86 U/kg/24 h to 0.7 U/kg/24 h (after 6 months) and to 0,75 U/kg/24 h (after 12 months) and 0.77 U/kg/24 h after 18 months. In the MI-1 group HbA1c increased significantly from 7.0% to 7.4% in the 6th month and to 7.3% in the 18th month. DIR increased significantly from 0.68 U/kg/24 h to 0.76 U/kg/24 h; 0,8 U/kg/24 h and 0.84 U/kg/24 h after 6, 12, and 18 months respectively. There were no significant differences in HbA1c and DIR values in CSII-2 group after 18 months of observation. Significant difference of DIR was found in: CSII-1 vs. MI-1 and CSII-2 (p<0.05) in all study points. The highest number of severe hypoglycemic episodes and DKA was found in the MI-1 group.

Conclusion: CSII in T1DM children under 10 yrs of age provides good metabolic control, is associated with reduced insulin requirement and its safety is comparable to the older children treated with the same modality.

背景:目前,持续皮下胰岛素输注(CSII)作为一种功能强化胰岛素治疗方法是最生理的胰岛素输注方式。近年来,胰岛素泵治疗已更频繁地用于儿科糖尿病,而这种治疗在10岁以下的最年轻儿童群体中的应用相对较新。本研究的目的是评估胰岛素泵对青春期前1型糖尿病(T1DM)儿童CSII的疗效。材料与方法:比较三组T1DM患儿胰岛素强化治疗的疗效。第一组30例CSII患儿,平均年龄6.7+/-2.2 SD年(CSII-1)。2组25例患儿接受多次注射(MI-1)治疗,平均年龄7.0+/-1.5 SD年;3-35例患儿接受CSII治疗,平均年龄13.9+/-2.1 SD年(CSII-2组)。CSII-1组和MI-1组患儿年龄具有可比性。各组T1DM持续时间相同。6、12、18个月后分析以下参数:HbA1c、每日胰岛素需用量(DIR) U/kg、严重低血糖发作次数和糖尿病酮症酸中毒(DKA)。结果:18个月后CSII-1 HbA1c从7.1%下降到6.9%,DIR从0.86 U/kg/24 h(6个月后)显著降低到0.7 U/kg/24 h(12个月后)和0.77 U/kg/24 h(18个月后)。MI-1组HbA1c在第6个月和第18个月分别从7.0%和7.4%显著升高至7.3%。DIR由0.68 U/kg/24 h显著增加至0.76 U/kg/24 h;6、12、18个月后分别为0、8 U/kg/24 h和0.84 U/kg/24 h。观察18个月后,CSII-2组患者HbA1c、DIR值无显著差异。CSII-1与MI-1、CSII-2的DIR差异有统计学意义(p)结论:10岁以下T1DM患儿CSII能很好地控制代谢,降低胰岛素需求,其安全性与采用相同方式治疗的大龄患儿相当。
{"title":"[Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].","authors":"Mariola Minkina-Pedras,&nbsp;Przemysława Jarosz-Chobot,&nbsp;Ewa Małecka-Tendera,&nbsp;Grazyna Deja","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Currently continuous subcutaneous insulin infusion (CSII) as a method of functional intensive insulin therapy is the most physiological way to administer insulin. In recent years treatment with insulin pumps has been used more frequently in the paediatric diabetes whereas application of this kind of therapy is relatively new in the youngest group of children below the age of 10 years. THE AIM of the study was to assess the efficiency of CSII by means of insulin pumps in prepubertal children with type 1 diabetes mellitus (T1DM).</p><p><strong>Materials and methods: </strong>Three groups of T1DM children on intensive insulin therapy were compared. Group 1 comprised 30 children with CSII in the mean age 6.7+/-2.2 SD years (CSII-1). In group 2 were 25 children treated with multiple injections (MI-1) in the mean age 7.0+/-1.5 SD years and in group 3-35 children in the mean age 13.9+/-2.1 SD years treated with CSII (group CSII-2). The age of children was comparable in group CSII-1 and MI-1. T1DM duration was the same for all groups. After 6, 12, 18 months the following parameters were analyzed: HbA1c, daily insulin requirement (DIR) U/kg, number of severe hypoglycemic episodes and diabetic ketoacidosis (DKA).</p><p><strong>Results: </strong>After 18 months in CSII-1 HbA1c decreased insignificantly from 7.1% to 6.9% and DIR was significantly reduced from 0.86 U/kg/24 h to 0.7 U/kg/24 h (after 6 months) and to 0,75 U/kg/24 h (after 12 months) and 0.77 U/kg/24 h after 18 months. In the MI-1 group HbA1c increased significantly from 7.0% to 7.4% in the 6th month and to 7.3% in the 18th month. DIR increased significantly from 0.68 U/kg/24 h to 0.76 U/kg/24 h; 0,8 U/kg/24 h and 0.84 U/kg/24 h after 6, 12, and 18 months respectively. There were no significant differences in HbA1c and DIR values in CSII-2 group after 18 months of observation. Significant difference of DIR was found in: CSII-1 vs. MI-1 and CSII-2 (p<0.05) in all study points. The highest number of severe hypoglycemic episodes and DKA was found in the MI-1 group.</p><p><strong>Conclusion: </strong>CSII in T1DM children under 10 yrs of age provides good metabolic control, is associated with reduced insulin requirement and its safety is comparable to the older children treated with the same modality.</p>","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"11 3","pages":"171-6"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25642250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy]. [甲巯咪唑治疗期间青少年Graves病特定单核细胞共刺激分子(CD28-CTLA-4/B7)表达分析]。
Artur Bossowski, Anna Stasiak-Barmuta, Mirosława Urban, Cornelia Rinderle

CD28 and CTLA-4 are glycoprotein molecules providing the potent costimulatory signal for T cells activation and proliferation via interactions with their ligands B7/BB1 molecule, present on the surface of Ag-presenting cells (APC). The present study was performed to elucidate the relationship between CTLA-4/CD28 molecules and stimulating (TSAb) or blocking (TBAb) antibodies to the TSH-receptor in Graves' disease. The aim of the study was to estimate the expression of CTLA-4 (cytolitic T lymphocyte associated antigen-4, CD152), CD28, B7.1 (CD80) and CD7.2 (CD86) molecules on peripheral blood cells in patients with Graves' disease (GD) (n=28, mean age 15.4), in patients with nontoxic nodular goiter (NTNG) (n=28, mean age 15.6 years) in comparison with sex- and age-matched healthy control subjects (n=28, mean age 15.9 years). The expression of the costimulatory molecules on mononuclear cells was analyzed by the three-color flow cytometry using a Coulter EPICS XL cytometer. Detection of stimulating and blocking antibodies to the TSH-receptor using JPO9 CHO cells in unfractionated serum was measured by a highly sensitive commercial radioimmunoassay. In untreated Graves' patients we observed a significant increase of CD152+ (p<0.004, p<0.004, p<0.001) and CD28+ (p<0.02, p<0.02, p<0.02) T lymphocytes in comparison to the non-toxic nodular goiter patients, healthy control subjects and euthyroid Graves' patients. After 2-6 months of methimazole therapy, the percentages of these cells in the peripheral blood of hyperthyroid patients returned to normal values. The analysis of CD3+ T lymphocytes co-expressing CD152 and CD28 antigens on peripheral blood revealed increased percentages of CTLA-4/CD28 positive cells in patients with Graves' disease (p<0.004, p<0.04) compared to the controls and euthyroid Graves' patients, while B7.1 (CD80) and B7.2 (CD86) molecules were detected only in some hyperthyroid patients on activated monocytes. In addition, 75% of children with untreated hyperthyroidism had positive TSAbs, whereas TBAbs were measured in 3 out of 7 TSAb negative patients with Graves' disease. In untreated Graves' patients a correlation between percentage of CD152+ T cells and serum level of stimulating and blocking antibodies to the TSH-receptor was found, while no such correlation was detected in relation to CD28+ T cells. We conclude that the changes of the expression of costimulatory molecules on peripheral blood mononuclear cells could be an important marker of activity of an autoimmune process in children and adolescents with Graves' disease and that their levels are modulated by thyroestatic treatment.

CD28和CTLA-4是糖蛋白分子,通过与Ag-presenting cells (APC)表面的配体B7/BB1分子相互作用,为T细胞的激活和增殖提供有效的共刺激信号。本研究旨在阐明CTLA-4/CD28分子与Graves病tsh受体刺激(TSAb)或阻断(TBAb)抗体之间的关系。该研究的目的是估计CTLA-4(细胞溶性T淋巴细胞相关抗原-4,CD152)、CD28、B7.1 (CD80)和CD7.2 (CD86)分子在格雷夫斯病(GD)患者(n=28,平均年龄15.4)和无毒结节性甲状腺肿(NTNG)患者(n=28,平均年龄15.6岁)外周血细胞上的表达,并与性别和年龄匹配的健康对照组(n=28,平均年龄15.9岁)进行比较。用库尔特EPICS XL细胞仪三色流式细胞术分析共刺激分子在单个核细胞上的表达。使用未分离血清中的JPO9 CHO细胞检测tsh受体的刺激和阻断抗体,采用高灵敏度的商业放射免疫测定法。在未经治疗的Graves患者中,我们观察到CD152+ (p
{"title":"[Analysis of costimulatory molecules (CD28-CTLA-4/B7) expression on chosen mononuclear cells in adolescents with Graves' disease during methimazole therapy].","authors":"Artur Bossowski,&nbsp;Anna Stasiak-Barmuta,&nbsp;Mirosława Urban,&nbsp;Cornelia Rinderle","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>CD28 and CTLA-4 are glycoprotein molecules providing the potent costimulatory signal for T cells activation and proliferation via interactions with their ligands B7/BB1 molecule, present on the surface of Ag-presenting cells (APC). The present study was performed to elucidate the relationship between CTLA-4/CD28 molecules and stimulating (TSAb) or blocking (TBAb) antibodies to the TSH-receptor in Graves' disease. The aim of the study was to estimate the expression of CTLA-4 (cytolitic T lymphocyte associated antigen-4, CD152), CD28, B7.1 (CD80) and CD7.2 (CD86) molecules on peripheral blood cells in patients with Graves' disease (GD) (n=28, mean age 15.4), in patients with nontoxic nodular goiter (NTNG) (n=28, mean age 15.6 years) in comparison with sex- and age-matched healthy control subjects (n=28, mean age 15.9 years). The expression of the costimulatory molecules on mononuclear cells was analyzed by the three-color flow cytometry using a Coulter EPICS XL cytometer. Detection of stimulating and blocking antibodies to the TSH-receptor using JPO9 CHO cells in unfractionated serum was measured by a highly sensitive commercial radioimmunoassay. In untreated Graves' patients we observed a significant increase of CD152+ (p<0.004, p<0.004, p<0.001) and CD28+ (p<0.02, p<0.02, p<0.02) T lymphocytes in comparison to the non-toxic nodular goiter patients, healthy control subjects and euthyroid Graves' patients. After 2-6 months of methimazole therapy, the percentages of these cells in the peripheral blood of hyperthyroid patients returned to normal values. The analysis of CD3+ T lymphocytes co-expressing CD152 and CD28 antigens on peripheral blood revealed increased percentages of CTLA-4/CD28 positive cells in patients with Graves' disease (p<0.004, p<0.04) compared to the controls and euthyroid Graves' patients, while B7.1 (CD80) and B7.2 (CD86) molecules were detected only in some hyperthyroid patients on activated monocytes. In addition, 75% of children with untreated hyperthyroidism had positive TSAbs, whereas TBAbs were measured in 3 out of 7 TSAb negative patients with Graves' disease. In untreated Graves' patients a correlation between percentage of CD152+ T cells and serum level of stimulating and blocking antibodies to the TSH-receptor was found, while no such correlation was detected in relation to CD28+ T cells. We conclude that the changes of the expression of costimulatory molecules on peripheral blood mononuclear cells could be an important marker of activity of an autoimmune process in children and adolescents with Graves' disease and that their levels are modulated by thyroestatic treatment.</p>","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"10 2","pages":"93-101"},"PeriodicalIF":0.0,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24780181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Association of brain computed tomography images of intracranial calcifications in three different cases of hypoparathyroidism]. [三种不同甲状旁腺功能减退症颅内钙化的脑计算机断层图像的关联]。
Katarzyna Ziora, Joanna Oświecimska, Gabriela Geisler, Katarzyna Broll-Waśka, Jan Głowacki, Jolanta Kozłowska, Antoni Dyduch

The problem of intracranial calcifications in children has not been widely discussed in the literature yet. The aim of this study is to emphasise different clinical aspects of intracranial calcifications found in subcortical nuclei and cerebellum in children with disturbed calcium metabolism. We report three different cases of hypoparathyroidism in children in whom similar radiological changes on computed tomography (CT) of the brain were found. An 11-year-old boy was referred to us after episode of tetany. We confirmed the diagnosis of idiopatic hypoparathyroidism (presence of Chvostek and Trousseau signs, hypocalcemia, hyperphosphatemia, low parathormone serum concentration). On brain CT small, symmetric calcifications in the subcortical nuclei and frontal lobes were imaged. A diagnosis of pseudohypoparathyroidism type Ib in 10-year-old girl was established on the basis of clinical symptoms (syncope with seizures, recurrent carpopedal spasms in the past) and laboratory investigations (hypocalcemia, hyperphosphatemia, high parathormone serum concentration). In 11-year-old girl autoimmune polyglandular syndrome type I was diagnosed (hypoparathyroidism with chronic mucocutaneous candidiasis and nail dystrophy from the age of 2). CT of the brain showed multiple irregular symmetric calcifications in cerebellar hemispheres, internal capsula and subcortical nuclei on the border of white and grey matter in both frontal lobes.

儿童颅内钙化问题在文献中尚未得到广泛讨论。本研究的目的是强调在钙代谢紊乱的儿童中发现的皮质下核和小脑颅内钙化的不同临床方面。我们报告了三例不同的儿童甲状旁腺功能减退症,他们在计算机断层扫描(CT)上发现了类似的放射学变化。一个11岁的男孩在抽搐发作后被转介到我们这里。我们确诊为特发性甲状旁腺功能低下(Chvostek和Trousseau症状,低钙血症,高磷血症,低甲状旁腺激素血清浓度)。脑CT显示皮质下核和额叶小而对称的钙化。根据临床症状(晕厥伴癫痫发作,既往腕足痉挛复发)和实验室检查(低钙血症、高磷血症、高甲状旁腺激素血清浓度),诊断为10岁女童假甲状旁腺功能低下Ib型。11岁女童,诊断为自身免疫性多腺综合征I型(2岁起甲状旁腺功能减退伴慢性皮肤黏液念珠菌病及甲营养不良)。脑部CT示小脑半球、内包膜及双额叶白质和灰质边界皮质下核多发不规则对称钙化。
{"title":"[Association of brain computed tomography images of intracranial calcifications in three different cases of hypoparathyroidism].","authors":"Katarzyna Ziora,&nbsp;Joanna Oświecimska,&nbsp;Gabriela Geisler,&nbsp;Katarzyna Broll-Waśka,&nbsp;Jan Głowacki,&nbsp;Jolanta Kozłowska,&nbsp;Antoni Dyduch","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The problem of intracranial calcifications in children has not been widely discussed in the literature yet. The aim of this study is to emphasise different clinical aspects of intracranial calcifications found in subcortical nuclei and cerebellum in children with disturbed calcium metabolism. We report three different cases of hypoparathyroidism in children in whom similar radiological changes on computed tomography (CT) of the brain were found. An 11-year-old boy was referred to us after episode of tetany. We confirmed the diagnosis of idiopatic hypoparathyroidism (presence of Chvostek and Trousseau signs, hypocalcemia, hyperphosphatemia, low parathormone serum concentration). On brain CT small, symmetric calcifications in the subcortical nuclei and frontal lobes were imaged. A diagnosis of pseudohypoparathyroidism type Ib in 10-year-old girl was established on the basis of clinical symptoms (syncope with seizures, recurrent carpopedal spasms in the past) and laboratory investigations (hypocalcemia, hyperphosphatemia, high parathormone serum concentration). In 11-year-old girl autoimmune polyglandular syndrome type I was diagnosed (hypoparathyroidism with chronic mucocutaneous candidiasis and nail dystrophy from the age of 2). CT of the brain showed multiple irregular symmetric calcifications in cerebellar hemispheres, internal capsula and subcortical nuclei on the border of white and grey matter in both frontal lobes.</p>","PeriodicalId":11550,"journal":{"name":"Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych","volume":"10 2","pages":"133-7"},"PeriodicalIF":0.0,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24779563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1